Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 2, keine Gesamtzahl für „crizotinib“
Suchtreffer
Begriffe & Kennungen
Xalkori · 4.8 · Adult patients with NSCLC In clinical studies with crizotinib in adult patients with either ALK-positive or RO
Eintrag öffnenXalkori · 4.8 · Adult patients with NSCLC In studies with crizotinib in adult patients with either ALK-positive or ROS1-positi
Eintrag öffnenXalkori · 4.8 · Based on the Visual Symptom Assessment Questionnaire (VSAQ-ALK), adult patients treated with crizotinib in Stu
Eintrag öffnenXalkori · 4.8 · In adult patients with new onset of Grade 4 visual loss, crizotinib treatment should be discontinued and ophth
Eintrag öffnenXalkori · 4.8 · In clinical studies of adult patients with NSCLC treated with crizotinib, events of gastrointestinal perforati
Eintrag öffnenXalkori · 4.8 · In clinical studies of crizotinib in adult patients with either ALK-positive or ROS1-positive advanced NSCLC,
Eintrag öffnenXalkori · 4.8 · In clinical studies with crizotinib, 41 patients with ALK-positive ALCL or ALK-positive IMT, vision disorder h
Eintrag öffnenXalkori · 4.8 · Paediatric patients ILD/pneumonitis was reported in clinical studies with crizotinib in paediatric patients wi
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Paediatric patients In clinical studies with crizotinib in 110 paediatric patients with a variety of tumour ty
Eintrag öffnenXalkori · 4.8 · Table 9. Adverse reactions reported in crizotinib clinical studies of NSCLC (N=1722) System organ class Very c
Eintrag öffnenXalkori · 4.8 · The safety profile of crizotinib in paediatric patients with ALK-positive ALCL or with ALK-positive IMT was ge
Eintrag öffnencrizotinib
Eintrag öffnencrizotinib
Eintrag öffnen